Literature DB >> 1279171

Tenascin and fibronectin distribution in human normal and pathological synovium.

M Cutolo1, M Picasso, M Ponassi, M Z Sun, E Balza.   

Abstract

Tenascin is a glycoprotein found mainly in the extracellular matrix of developing and malignant tissues. The distribution of this molecule in normal and pathological synovia from patients with osteoarthritis (OA) and rheumatoid arthritis (RA) was investigated by indirect immunofluorescence utilizing specific monoclonal antibodies. The same technique was used to study total fibronectin (tFn) in synovial tissues as well as ED-A and ED-B containing fibronectin (Fn) isoforms (A-Fn, B-Fn), generated by alternative splicing of pre-mRNA. Tenascin was found in normal synovium just beneath the whole lining cell layer. However, a higher density and spreading pattern of distribution was observed in OA and RA sections. A-Fn and B-Fn isoforms were prominent and widespread throughout the normal synovial lining; in hypercellular synovial lining (in RA and OA samples), A-Fn and B-Fn were also observed spreading in the sublining, as well as tFn.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279171

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment.

Authors:  Wei Jia; Hong Li; You-Wen He
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

2.  Expression of tenascin in joint-associated tissues during development and postnatal growth.

Authors:  E J Mackie; S Ramsey
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

3.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

4.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

5.  Expression of cellular fibronectin and tenascin in the rabbit cornea after excimer laser photorefractive keratectomy: a 12 month study.

Authors:  T Latvala; K Tervo; R Mustonen; T Tervo
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

6.  Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins.

Authors:  N Rinaldi; M Schwarz-Eywill; D Weis; P Leppelmann-Jansen; M Lukoschek; U Keilholz; T F Barth
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

7.  The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation.

Authors:  S Schenk; R Chiquet-Ehrismann; E J Battegay
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

8.  Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis.

Authors:  J Kriegsmann; A Berndt; T Hansen; L Borsi; L Zardi; R Bräuer; P K Petrow; M Otto; C J Kirkpatrick; S Gay; H Kosmehl
Journal:  Rheumatol Int       Date:  2003-04-24       Impact factor: 2.631

9.  Basement membrane proteins in synovial membrane: distribution in rheumatoid arthritis and synthesis by fibroblast-like cells.

Authors:  M Schneider; B Voss; J Rauterberg; M Menke; T Pauly; R K Miehlke; J Friemann; U Gerlach
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

10.  Loss of laminin and of the laminin receptor integrin subunit alpha 6 in situ correlates with cytokine induced down regulation of alpha 6 on fibroblast-like synoviocytes from rheumatoid arthritis.

Authors:  N Rinaldi; T F Barth; D Weis; M Schwarz-Eywill; A Pezzutto; M Lukoschek; D Brocai; B Brado
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.